Insider · CIK 0001789815

Tatsis Ourania

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001789815

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-21	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+8,251 sh	—	—	53,572
2026-07-02	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−1,500 sh	$524.99	−$787K	45,321
2026-05-07	ODTXOdyssey Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+27.4K sh	—	—	27,393
2026-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−260 sh	$486.35	−$126K	46,763
2026-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−1,627 sh	$485.11	−$789K	47,023
2026-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−368 sh	$473.68	−$174K	48,650
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+5,789 sh	—	—	51,921
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−2,294 sh	$483.75	−$1.11M	49,627
2026-02-17	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−609 sh	$489.46	−$298K	49,018
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−3,804 sh	$487.76	−$1.86M	47,632
2026-02-13	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−1,500 sh	$499.99	−$750K	46,132
2026-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−466 sh	$460.43	−$215K	51,436
2026-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−2,140 sh	$468.41	−$1M	51,902
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+7,866 sh	—	—	50,159
2026-01-22	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+3,883 sh	—	—	54,042
2026-01-07	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−4,500 sh	$474.99	−$2.14M	42,293
2025-12-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−4,500 sh	$449.99	−$2.02M	46,793
2025-07-25	Verve Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−268K sh	—	—	0
2025-07-25	Verve Therapeutics, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−42.2K sh	—	—	0
2025-06-05	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+42.2K sh	—	—	42,200
2025-03-10	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−3,242 sh	$499.99	−$1.62M	51,239
2025-03-04	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−4,058 sh	$485.49	−$1.97M	54,481
2025-02-27	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−530 sh	$475.34	−$252K	58,539
2025-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−4,962 sh	$479.61	−$2.38M	59,069
2025-02-25	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−354 sh	$480.95	−$170K	64,031
2025-02-24	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−3,310 sh	$483.28	−$1.6M	64,385
2025-02-18	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−244 sh	$455.06	−$111K	67,695
2025-02-14	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−2,293 sh	$463.46	−$1.06M	67,939
2025-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+6,211 sh	—	—	70,232
2025-02-11	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−310 sh	$459.83	−$143K	64,021
2025-02-10	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−2,143 sh	$467.98	−$1M	64,331
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+10.3K sh	—	—	59,360
2025-02-04	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+7,114 sh	—	—	66,474
2024-06-26	Verve Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+268K sh	—	—	267,541
2024-06-03	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−2,175 sh	$460.00	−$1M	49,098
2024-05-31	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−2,250 sh	$445.00	−$1M	51,273
2024-05-30	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−2,350 sh	$439.11	−$1.03M	53,523
2024-02-26	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−354 sh	$425.70	−$151K	55,804
2024-02-23	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−3,309 sh	$431.79	−$1.43M	56,158
2024-02-21	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−360 sh	$421.77	−$152K	59,467
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−3,373 sh	$420.58	−$1.42M	60,307
2024-02-20	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−480 sh	$420.79	−$202K	59,827
2024-02-16	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−4,499 sh	$424.01	−$1.91M	63,680
2024-02-12	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−314 sh	$420.24	−$132K	68,179
2024-02-09	VRTXVERTEX PHARMACEUTICALS INC / MAF Tax Payment	EVP, Chief Reg. & Quality Off.	FTax Payment	−2,100 sh	$422.74	−$888K	68,493
2024-02-07	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+7,114 sh	—	—	70,593
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+6,976 sh	—	—	55,613
2024-02-06	VRTXVERTEX PHARMACEUTICALS INC / MAA Award	EVP, Chief Reg. & Quality Off.	AAward	+7,866 sh	—	—	63,479
2023-08-23	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−2,500 sh	$355.00	−$888K	48,637
2023-08-10	VRTXVERTEX PHARMACEUTICALS INC / MAS Sale	EVP, Chief Reg. & Quality Off.	SSale	−5,750 sh	$345.79	−$1.99M	51,137

Recent filings

Accepted (ET)
Jul 234
Tatsis Ourania0000875320-26-000253
SEC(opens sec.gov)
Jul 74
Tatsis Ourania0000875320-26-000245
SEC(opens sec.gov)
May 114
Tatsis Ourania0001193125-26-217588
SEC(opens sec.gov)
Feb 264
Tatsis Ourania0000875320-26-000120
SEC(opens sec.gov)
Feb 194
Tatsis Ourania0000875320-26-000098
SEC(opens sec.gov)
Feb 184
Tatsis Ourania0000875320-26-000076
SEC(opens sec.gov)
Feb 124
Tatsis Ourania0000875320-26-000052
SEC(opens sec.gov)
Jan 264
Tatsis Ourania0000875320-26-000026
SEC(opens sec.gov)
Jan 94
Tatsis Ourania0000875320-26-000004
SEC(opens sec.gov)
Dec 54
Tatsis Ourania0000875320-25-000244
SEC(opens sec.gov)
Jul 284
Tatsis Ourania0000950170-25-099252
SEC(opens sec.gov)
Jun 64
Tatsis Ourania0000950170-25-083227
SEC(opens sec.gov)

Companies

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE

BOSTON, MA, 02210